Medical device firm scores major win from FDA

Arthrex’s  Eclipse Total Shoulder Replacement System has been clinically proven in Europe and Canada with more than 20,000 successful implantations.


  • By
  • | 9:11 p.m. August 1, 2019
  • | 0 Free Articles Remaining!
Courtesy. rthrex Vice President of Strategic Development Dr. Larry Higgins.
Courtesy. rthrex Vice President of Strategic Development Dr. Larry Higgins.
  • Charlotte–Lee–Collier
  • Share

NAPLES — Orthopedic surgical device firm Arthrex won a major victory from the FDA Aug. 1, with agency announcing clearance of the company’s Eclipse Total Shoulder Replacement System.

The Eclipse system, the company says in a statement, is a novel, less invasive, bone-preserving total shoulder replacement that has been clinically proven in Europe and Canada with more than 20,000 successful implantations over the past 14 years. The system was the first total shoulder implant to replace traditional long stem fixation with short, fenestrated cage screw fixation for bone ingrowth, eliminating the need for bone cement, the release adds.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content